Follow on Google News News By Tag * Approach Resources * Eastman Chemical * Eegi.pk * Eline Entertainment * Eline Entertainment Group * Nasdaq:arex * Nuropro * More Tags... Industry News Country(s) Industry News
Follow on Google News | Eegi, Pwrm, Emn, Rgc, Arex Stock Market Update From Crwepicks.comEline Entertainment Group, Inc. (PINK SHEETS:EEGI) announced recently that the company has entered into merger discussions with China-based video game designer Vu365.
By: DjSkribbleZ EEGImanagement feels that this is a significant event that merits reporting to the market. Management believes that this merger is imminent, as Vu365 has been looking to enter the USA markets for quite some time, and virtually exhausted its patience in discussion with another publicly traded company. EEGI management being able to accommodate VU365 needs is taking aggressive action. According to sources, Vu365 offers revenues in the $2 million USD range, with profits of $500,000 USD. Eline Entertainment Group, Inc. operates in the educational industry in China. It operates 12 educational training centers for nursery students; and 4 training programs. The company was formerly known as Eline Music.com, Inc. and changed its name to Eline Entertainment Group, Inc. in April 2001. Eline Entertainment Group, Inc. is based in Hendersen, Nevada. ************* Power3 Medical Products, Inc. (PWRM.OB) recently delivered four poster presentations at the 2010 ICAD. These presentations discussed PWRM’s diagnostic test, NuroPro, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials. “In preparation for commercialization, our objective at this meeting was to show how Power3’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief ScACientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.” Power3 Medical Products, Inc., a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. The company?s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer?s disease, and Parkinson?s disease. ************* Eastman Chemical Company plans to add production of cellulose triacetate (CTA) at its Kingsport, Tenn., site. CTA is a material widely used in the liquid crystal display (LCD) industry in the manufacture of polarizer films for computers, televisions, monitors, and handheld devices. The project will increase EMN’s total CTA capacity by almost 70 percent and start up is expected in the first quarter 2012. ************* Regal Entertainment Group , a leading motion picture exhibitor owning and operating the largest theatre circuit in the United States, recently reported that the industry-leading customer loyalty program, Regal Crown Club, will celebrate ten years by honoring its most dedicated members. In 2011 Regal Crown Club will reach its 10 year anniversary. In celebration, RGC is creating a new Elite status to recognize the most loyal movie theatre patrons. ************* Approach Resources Inc. intends, subject to market conditions, to offer 5,000,000 shares of its common stock in an underwritten offering. The offering is being made pursuant to an effective shelf registration statement filed with the U.S. Securities and Exchange Commission (“SEC”). AREX expects to grant the underwriters a 30-day option, solely to cover over-allotments, to purchase an additional 750,000 shares of its common stock. AREX intends to use the net proceeds from the offering to fund the development of its Wolffork oil resource play, for potential acquisitions of oil and gas leases and other properties in its core areas of operations and for general working capital needs. Pending these uses, AREX intends to repay outstanding borrowings under its revolving credit facility. ******************************************* Sign-Up For Free Stock Alerts At http://crwepicks.com/ ******************************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/ ******************************************* End
Account Email Address Disclaimer Report Abuse
|
|